NASDAQ:PETS - PetMed Express Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $41.00
  • Forecasted Upside: 33.33 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$30.75
▲ +0.02 (0.07%)
1 month | 3 months | 12 months
Get New PetMed Express Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PETS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PETS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$41.00
▲ +33.33% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for PetMed Express in the last 3 months. The average price target is $41.00, with a high forecast of $41.00 and a low forecast of $41.00. The average price target represents a 33.33% upside from the last price of $30.75.
Buy
The current consensus among 1 investment analysts is to buy stock in PetMed Express. This rating has held steady since December 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/11/2021SidotiUpgradeNeutral ➝ BuyLow
i
3/5/2021SidotiUpgradeNeutral ➝ BuyHigh
i
1/27/2021SidotiDowngradeBuy ➝ NeutralHigh
i
8/19/2020SidotiUpgradeNeutral ➝ Buy$37.00 ➝ $41.00Medium
i
Rating by Anthony Lebiedzinski at Sidoti
4/9/2020SidotiDowngradeBuy ➝ Neutral$31.00Low
i
Rating by Anthony Lebiedzinski at Sidoti
3/12/2020SidotiUpgradeNeutral ➝ Buy$31.00Medium
i
Rating by Anthony Lebiedzinski at Sidoti
2/24/2020SidotiDowngradeBuy ➝ Neutral$31.00High
i
Rating by Anthony Lebiedzinski at Sidoti
1/2/2020SidotiReiterated RatingBuy$29.00Low
i
Rating by Anthony Lebiedzinski at Sidoti
10/17/2019Craig HallumBoost Price TargetHold$15.00 ➝ $20.00Low
i
Rating by Kevin Ellich at Craig Hallum
8/16/2019Craig HallumDowngradeBuy ➝ Hold$15.00High
i
1/23/2019Craig HallumLower Price TargetSell$25.00 ➝ $18.00High
i
7/9/2018Craig HallumReiterated RatingHold ➝ Sell$38.00 ➝ $32.00High
i
Rating by K. Ellich at Craig Hallum
6/15/2018CL KingInitiated CoverageNeutralHigh
i
5/8/2018Craig HallumLower Price TargetHold$38.00Low
i
1/3/2018Northcoast ResearchSet Price TargetBuy$58.00High
i
Rating by E. Snyder at Northcoast Research
10/27/2017Noble FinancialReiterated RatingHoldN/A
i
Rating by Michael Kupinski at Noble Financial
10/2/2017Credit Suisse GroupReiterated RatingUnderperform$19.00Low
i
8/24/2017SidotiUpgradeNeutral ➝ Buy$47.00High
i
8/21/2017Craig HallumReiterated RatingHold$43.00 ➝ $40.00High
i
Rating by K. Ellich at Craig Hallum
7/26/2017Noble FinancialReiterated RatingHoldLow
i
Rating by Michael Kupinski at Noble Financial
7/24/2017Northcoast ResearchUpgradeNeutral ➝ Buy$54.00High
i
Rating by E. Snyder at Northcoast Research
7/11/2017Craig HallumDowngradeBuy ➝ HoldHigh
i
Rating by K. Ellich at Craig Hallum
4/4/2017Craig HallumUpgradeHold ➝ BuyLow
i
Rating by K. Ellich at Craig Hallum
8/16/2016Credit Suisse GroupReiterated RatingSell$13.00N/A
i
5/9/2016Craig HallumUpgradeSell ➝ HoldN/A
i
Rating by M. Bartlett at Craig Hallum
(Data available from 4/21/2016 forward)
PetMed Express logo
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.
Read More

Today's Range

Now: $30.75
$30.16
$31.11

50 Day Range

MA: $33.68
$30.73
$36.48

52 Week Range

Now: $30.75
$27.67
$57.00

Volume

341,631 shs

Average Volume

772,211 shs

Market Capitalization

$623.33 million

P/E Ratio

20.50

Dividend Yield

3.64%

Beta

0.7

Frequently Asked Questions

What sell-side analysts currently cover shares of PetMed Express?

The following Wall Street sell-side analysts have issued reports on PetMed Express in the last year: Sidoti.
View the latest analyst ratings for PETS.

What is the current price target for PetMed Express?

1 Wall Street analysts have set twelve-month price targets for PetMed Express in the last year. Their average twelve-month price target is $41.00, suggesting a possible upside of 33.3%. Sidoti has the highest price target set, predicting PETS will reach $41.00 in the next twelve months. Sidoti has the lowest price target set, forecasting a price of $41.00 for PetMed Express in the next year.
View the latest price targets for PETS.

What is the current consensus analyst rating for PetMed Express?

PetMed Express currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PETS will outperform the market and that investors should add to their positions of PetMed Express.
View the latest ratings for PETS.

What other companies compete with PetMed Express?

Other companies that are similar to PetMed Express include Amazon.com, Netflix, Booking, Expedia Group, TripAdvisor, Overstock.com, 1-800-FLOWERS.COM, Groupon and CarParts.com.

How do I contact PetMed Express' investor relations team?

PetMed Express' physical mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company's listed phone number is 561-526-4444. The official website for PetMed Express is www.1800petmeds.com.